Vistagen Therapeutics Inc (VTGN)
4.75
-0.07
(-1.45%)
USD |
NASDAQ |
Apr 24, 16:00
4.75
0.00 (0.00%)
After-Hours: 20:00
Vistagen Therapeutics Market Cap: 128.37M for April 24, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 23, 2024 | 130.26M |
| April 22, 2024 | 129.18M |
| April 19, 2024 | 128.64M |
| April 18, 2024 | 127.02M |
| April 17, 2024 | 126.21M |
| April 16, 2024 | 125.67M |
| April 15, 2024 | 128.37M |
| April 12, 2024 | 132.15M |
| April 11, 2024 | 143.37M |
| April 10, 2024 | 137.83M |
| April 09, 2024 | 145.13M |
| April 08, 2024 | 139.72M |
| April 05, 2024 | 136.21M |
| April 04, 2024 | 142.96M |
| April 03, 2024 | 145.40M |
| April 02, 2024 | 145.94M |
| April 01, 2024 | 145.94M |
| March 28, 2024 | 142.69M |
| March 27, 2024 | 123.51M |
| March 26, 2024 | 117.56M |
| March 25, 2024 | 115.67M |
| March 22, 2024 | 112.70M |
| March 21, 2024 | 113.91M |
| March 20, 2024 | 112.70M |
| March 19, 2024 | 112.15M |
| Date | Value |
|---|---|
| March 18, 2024 | 109.72M |
| March 15, 2024 | 109.45M |
| March 14, 2024 | 105.94M |
| March 13, 2024 | 113.51M |
| March 12, 2024 | 110.53M |
| March 11, 2024 | 112.70M |
| March 08, 2024 | 113.78M |
| March 07, 2024 | 114.45M |
| March 06, 2024 | 119.72M |
| March 05, 2024 | 121.34M |
| March 04, 2024 | 131.07M |
| March 01, 2024 | 137.02M |
| February 29, 2024 | 138.10M |
| February 28, 2024 | 140.80M |
| February 27, 2024 | 142.96M |
| February 26, 2024 | 136.34M |
| February 23, 2024 | 133.50M |
| February 22, 2024 | 132.96M |
| February 21, 2024 | 130.13M |
| February 20, 2024 | 135.13M |
| February 16, 2024 | 137.83M |
| February 15, 2024 | 146.48M |
| February 14, 2024 | 145.67M |
| February 13, 2024 | 132.42M |
| February 12, 2024 | 139.18M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
12.43M
Minimum
Jun 26 2023
660.66M
Maximum
Jul 01 2021
151.71M
Average
51.87M
Median
Aug 17 2023
Market Cap Benchmarks
| Ardelyx Inc | 1.497B |
| Axsome Therapeutics Inc | 3.374B |
| Vir Biotechnology Inc | 1.087B |
| Immuneering Corp | 44.22M |
| NovaBay Pharmaceuticals Inc | 2.242M |
Market Cap Related Metrics
| PS Ratio | 61.49 |
| Price to Book Value | 1.041 |
| Price | 4.75 |
| Earnings Yield | -73.88% |